Andersen, K. G., Rambaut, A., Lipkin, W. I., Holmes, E. C., and Garry, R. F. (2020). The proximal origin of SARS-CoV-2. Nat. Med. 26, 450–452. doi:10.1038/s41591-020-0820-9.
Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., et al. (2000). Gene ontology: Tool for the unification of biology. Nat. Genet. 25, 25–29. doi:10.1038/75556.
Bader, G. D., and Hogue, C. W. V (2003). An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinformatics 4, 2. doi:10.1186/1471-2105-4-2.
Bailey-Elkin, B. A., Knaap, R. C. M., Johnson, G. G., Dalebout, T. J., Ninaber, D. K., van Kasteren, P. B., et al. (2014). Crystal Structure of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Papain-like Protease Bound to Ubiquitin Facilitates Targeted Disruption of Deubiquitinating Activity to Demonstrate Its Role in Innate Immune Suppression. J. Biol. Chem. 289, 34667–34682. doi:10.1074/jbc.M114.609644.
Benjamini, Y., and Hochberg, Y. (1995). Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J. R. Stat. Soc. Ser. B 57, 289–300. doi:10.1111/j.2517-6161.1995.tb02031.x.
Carbon, S., Douglass, E., Dunn, N., Good, B., Harris, N. L., Lewis, S. E., et al. (2019). The Gene Ontology Resource: 20 years and still GOing strong. Nucleic Acids Res. 47, D330–D338. doi:10.1093/nar/gky1055.
Chu, H., Chan, J. F.-W., Wang, Y., Yuen, T. T.-T., Chai, Y., Hou, Y., et al. (2020). Comparative replication and immune activation profiles of SARS-CoV-2 and SARS-CoV in human lungs: an ex vivo study with implications for the pathogenesis of COVID-19. Clin. Infect. Dis. doi:10.1093/cid/ciaa410.
Danesh, A., Cameron, C. M., León, A. J., Ran, L., Xu, L., Fang, Y., et al. (2011). Early gene expression events in ferrets in response to SARS coronavirus infection versus direct interferon-alpha2b stimulation. Virology 409, 102–112. doi:10.1016/j.virol.2010.10.002.
de Bruijn, M. H., and Fey, G. H. (1985). Human complement component C3: cDNA coding sequence and derived primary structure. Proc. Natl. Acad. Sci. 82, 708–712. doi:10.1073/pnas.82.3.708.
Dimitrov, D. S. (2003). The Secret Life of ACE2 as a Receptor for the SARS Virus. Cell 115, 652–653. doi:10.1016/S0092-8674(03)00976-0.
Drosten, C., Günther, S., Preiser, W., van der Werf, S., Brodt, H.-R., Becker, S., et al. (2003). Identification of a Novel Coronavirus in Patients with Severe Acute Respiratory Syndrome. N. Engl. J. Med. 348, 1967–1976. doi:10.1056/NEJMoa030747.
Dzimianski, J. V., Scholte, F. E. M., Bergeron, É., and Pegan, S. D. (2019). ISG15: It’s Complicated. J. Mol. Biol. 431, 4203–4216. doi:10.1016/j.jmb.2019.03.013.
Ewels, P., Magnusson, M., Lundin, S., and Käller, M. (2016). MultiQC: summarize analysis results for multiple tools and samples in a single report. Bioinformatics 32, 3047–3048. doi:10.1093/bioinformatics/btw354.
Francisco-Cruz, A., Aguilar-Santelises, M., Ramos-Espinosa, O., Mata-Espinosa, D., Marquina-Castillo, B., Barrios-Payan, J., et al. (2014). Granulocyte–macrophage colony-stimulating factor: not just another haematopoietic growth factor. Med. Oncol. 31, 774. doi:10.1007/s12032-013-0774-6.
Gallagher, T. M., and Buchmeier, M. J. (2001). Coronavirus Spike Proteins in Viral Entry and Pathogenesis. Virology 279, 371–374. doi:10.1006/viro.2000.0757.
García-Laorden, M. I., Lorente, J. A., Flores, C., Slutsky, A. S., and Villar, J. (2017). Biomarkers for the acute respiratory distress syndrome: how to make the diagnosis more precise. Ann. Transl. Med. 5, 283–283. doi:10.21037/atm.2017.06.49.
Gralinski, L. E., Sheahan, T. P., Morrison, T. E., Menachery, V. D., Jensen, K., Leist, S. R., et al. (2018). Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis. MBio 9. doi:10.1128/mBio.01753-18.
Haagmans, B. L., van den Brand, J. M. A., Raj, V. S., Volz, A., Wohlsein, P., Smits, S. L., et al. (2016). An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels. Science (80-. ). 351, 77–81. doi:10.1126/science.aad1283.
Hao, X., Lv, Q., Li, F., Xu, Y., and Gao, H. (2019). The characteristics of hDPP4 transgenic mice subjected to aerosol MERS coronavirus infection via an animal nose‐only exposure device. Anim. Model. Exp. Med. 2, 269–281. doi:10.1002/ame2.12088.
He, R., Dobie, F., Ballantine, M., Leeson, A., Li, Y., Bastien, N., et al. (2004a). Analysis of multimerization of the SARS coronavirus nucleocapsid protein. Biochem. Biophys. Res. Commun. 316, 476–483. doi:10.1016/j.bbrc.2004.02.074.
He, Y., Zhou, Y., Liu, S., Kou, Z., Li, W., Farzan, M., et al. (2004b). Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine. Biochem. Biophys. Res. Commun. 324, 773–781. doi:10.1016/j.bbrc.2004.09.106.
Ho, T.-Y., Wu, S.-L., Cheng, S.-E., Wei, Y.-C., Huang, S.-P., and Hsiang, C.-Y. (2004). Antigenicity and receptor-binding ability of recombinant SARS coronavirus spike protein. Biochem. Biophys. Res. Commun. 313, 938–947. doi:10.1016/j.bbrc.2003.11.180.
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., et al. (2020). SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell 181, 271-280.e8. doi:10.1016/j.cell.2020.02.052.
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., et al. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497–506. doi:10.1016/S0140-6736(20)30183-5.
Huang, D. W., Sherman, B. T., and Lempicki, R. A. (2009a). Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 37, 1–13. doi:10.1093/nar/gkn923.
Huang, D. W., Sherman, B. T., and Lempicki, R. A. (2009b). Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44–57. doi:10.1038/nprot.2008.211.
Jiaming, L., Yanfeng, Y., Yao, D., Yawei, H., Linlin, B., Baoying, H., et al. (2017). The recombinant N-terminal domain of spike proteins is a potential vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV) infection. Vaccine 35, 10–18. doi:10.1016/j.vaccine.2016.11.064.
Kanehisa, M. (2000). KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 28, 27–30. doi:10.1093/nar/28.1.27.
Kanehisa, M. (2019). Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28, 1947–1951. doi:10.1002/pro.3715.
Kanehisa, M., Sato, Y., Furumichi, M., Morishima, K., and Tanabe, M. (2019). New approach for understanding genome variations in KEGG. Nucleic Acids Res. 47, D590–D595. doi:10.1093/nar/gky962.
Khoury, M., Cuenca, J., Cruz, F. F., Figueroa, F. E., Rocco, P. R. M., and Weiss, D. J. (2020). Current Status of Cell-Based Therapies for Respiratory Virus Infections: Applicability to COVID-19. Eur. Respir. J. doi:10.1183/13993003.00858-2020.
Kim, D., Langmead, B., and Salzberg, S. L. (2015). HISAT: a fast spliced aligner with low memory requirements. Nat. Methods 12, 357–60. doi:10.1038/nmeth.3317.
Kim, D., Paggi, J. M., Park, C., Bennett, C., and Salzberg, S. L. (2019). Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat. Biotechnol. 37, 907–915. doi:10.1038/s41587-019-0201-4.
Kong, S. L., Chui, P., Lim, B., and Salto-Tellez, M. (2009). Elucidating the molecular physiopathology of acute respiratory distress syndrome in severe acute respiratory syndrome patients. Virus Res. 145, 260–269. doi:10.1016/j.virusres.2009.07.014.
Ksiazek, T. G., Erdman, D., Goldsmith, C. S., Zaki, S. R., Peret, T., Emery, S., et al. (2003). A Novel Coronavirus Associated with Severe Acute Respiratory Syndrome. N. Engl. J. Med. 348, 1953–1966. doi:10.1056/NEJMoa030781.
Lamers, M. M., Beumer, J., van der Vaart, J., Knoops, K., Puschhof, J., Breugem, T. I., et al. (2020). SARS-CoV-2 productively infects human gut enterocytes. Science (80-. )., eabc1669. doi:10.1126/science.abc1669.
Lex, A., Gehlenborg, N., Strobelt, H., Vuillemot, R., and Pfister, H. (2014). UpSet: Visualization of Intersecting Sets. IEEE Trans. Vis. Comput. Graph. 20, 1983–1992. doi:10.1109/TVCG.2014.2346248.
Li, F. (2005). Structure of SARS Coronavirus Spike Receptor-Binding Domain Complexed with Receptor. Science (80-. ). 309, 1864–1868. doi:10.1126/science.1116480.
Li, G., Fan, Y., Lai, Y., Han, T., Li, Z., Zhou, P., et al. (2020). Coronavirus infections and immune responses. J. Med. Virol. 92, 424–432. doi:10.1002/jmv.25685.
Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., et al. (2003). Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426, 450–454. doi:10.1038/nature02145.
Liang, W., Guan, W., Chen, R., Wang, W., Li, J., Xu, K., et al. (2020). Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 21, 335–337. doi:10.1016/S1470-2045(20)30096-6.
Liao, Y., Smyth, G. K., and Shi, W. (2014). featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923–930. doi:10.1093/bioinformatics/btt656.
Lindner, H. A., Lytvyn, V., Qi, H., Lachance, P., Ziomek, E., and Ménard, R. (2007). Selectivity in ISG15 and ubiquitin recognition by the SARS coronavirus papain-like protease. Arch. Biochem. Biophys. 466, 8–14. doi:10.1016/j.abb.2007.07.006.
Love, M. I., Huber, W., and Anders, S. (2014). Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550. doi:10.1186/s13059-014-0550-8.
Mastaglio, S., Ruggeri, A., Risitano, A. M., Angelillo, P., Yancopoulou, D., Mastellos, D. C., et al. (2020). The first case of COVID-19 treated with the complement C3 inhibitor AMY-101. Clin. Immunol. 215, 108450. doi:10.1016/j.clim.2020.108450.
Mastellos, D. C., Ricklin, D., and Lambris, J. D. (2019). Clinical promise of next-generation complement therapeutics. Nat. Rev. Drug Discov. 18, 707–729. doi:10.1038/s41573-019-0031-6.
Matsuyama, S., Nagata, N., Shirato, K., Kawase, M., Takeda, M., and Taguchi, F. (2010). Efficient Activation of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein by the Transmembrane Protease TMPRSS2. J. Virol. 84, 12658–12664. doi:10.1128/JVI.01542-10.
Micklem, K. J., and Sim, R. B. (1985). Isolation of complement-fragment-iC3b-binding proteins by affinity chromatography. The identification of p150,95 as an iC3b-binding protein. Biochem. J. 231, 233–236. doi:10.1042/bj2310233.
Mielech, A. M., Kilianski, A., Baez-Santos, Y. M., Mesecar, A. D., and Baker, S. C. (2014). MERS-CoV papain-like protease has deISGylating and deubiquitinating activities. Virology 450–451, 64–70. doi:10.1016/j.virol.2013.11.040.
Mitchell, H. D., Eisfeld, A. J., Sims, A. C., McDermott, J. E., Matzke, M. M., Webb-Robertson, B.-J. M., et al. (2013). A Network Integration Approach to Predict Conserved Regulators Related to Pathogenicity of Influenza and SARS-CoV Respiratory Viruses. PLoS One 8, e69374. doi:10.1371/journal.pone.0069374.
Morales, D. J., and Lenschow, D. J. (2013). The Antiviral Activities of ISG15. J. Mol. Biol. 425, 4995–5008. doi:10.1016/j.jmb.2013.09.041.
Ng, L. F., Hibberd, M. L., Ooi, E.-E., Tang, K.-F., Neo, S.-Y., Tan, J., et al. (2004). A human in vitro model system for investigating genome-wide host responses to SARS coronavirus infection. BMC Infect. Dis. 4, 34. doi:10.1186/1471-2334-4-34.
Peiris, J., Lai, S., Poon, L., Guan, Y., Yam, L., Lim, W., et al. (2003a). Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 361, 1319–1325. doi:10.1016/S0140-6736(03)13077-2.
Peiris, J. S. M., Yuen, K. Y., Osterhaus, A. D. M. E., and Stöhr, K. (2003b). The Severe Acute Respiratory Syndrome. N. Engl. J. Med. 349, 2431–2441. doi:10.1056/NEJMra032498.
Qihong Yan, Pingchao Li, Xianmiao Ye, Xiaohan Huang, Xiaoneng Mo, Qian Wang, Yudi Zhang, Kun Luo, Zhaoming Chen, Jia Luo, Xuefeng Niu, Ying Feng, Tianxing Ji, Bo Feng, Jinlin Wang, Feng Li, Fuchun Zhang, Fang Li, Jianhua Wang, Liqiang Feng, Zhilong Chen, L. C. (2020). Longitudinal peripheral blood transcriptional analysis of COVID-19 patients 1 captures disease progression and reveals potential biomarkers. medRxiv(preprint).
Raj, V. S., Mou, H., Smits, S. L., Dekkers, D. H. W., Müller, M. A., Dijkman, R., et al. (2013). Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature 495, 251–254. doi:10.1038/nature12005.
Ratia, K., Kilianski, A., Baez-Santos, Y. M., Baker, S. C., and Mesecar, A. (2014). Structural Basis for the Ubiquitin-Linkage Specificity and deISGylating Activity of SARS-CoV Papain-Like Protease. PLoS Pathog. 10, e1004113. doi:10.1371/journal.ppat.1004113.
Reghunathan, R., Jayapal, M., Hsu, L. Y., Chng, H. H., Tai, D., Leung, B. P., et al. (2005). Expression profile of immune response genes in patients with severe acute respiratory syndrome. BMC Immunol. 6. doi:10.1186/1471-2172-6-2.
Rian, K., Esteban-Medina, M., Hidalgo, M. R., Cubuk, C., Falco, M. M., Loucera, C., et al. (2020a). Mechanistic modeling of the SARS-CoV-2 disease map. bioRxiv(preprint) 19, 2020.04.12.025577. doi:10.1101/2020.04.12.025577.
Rian, K., Esteban-Medina, M., Hidalgo, M. R., Cubuk, C., Falco, M. M., Loucera, C., et al. (2020b). Mechanistic modeling of the SARS-CoV-2 disease map. bioRxiv(preprint) 19, 2020.04.12.025577. doi:10.1101/2020.04.12.025577.
Risitano, A. M., Mastellos, D. C., Huber-Lang, M., Yancopoulou, D., Garlanda, C., Ciceri, F., et al. (2020). Complement as a target in COVID-19? Nat. Rev. Immunol. doi:10.1038/s41577-020-0320-7.
Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W., et al. (2015). limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47–e47. doi:10.1093/nar/gkv007.
Selinger, C., Tisoncik-Go, J., Menachery, V. D., Agnihothram, S., Law, G., Chang, J., et al. (2014). Cytokine systems approach demonstrates differences in innate and pro-inflammatory host responses between genetically distinct MERS-CoV isolates. BMC Genomics 15, 1161. doi:10.1186/1471-2164-15-1161.
Shannon, P. (2003). Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks. Genome Res. 13, 2498–2504. doi:10.1101/gr.1239303.
Solovjov, D. A., Pluskota, E., and Plow, E. F. (2005). Distinct Roles for the α and β Subunits in the Functions of Integrin α M β 2. J. Biol. Chem. 280, 1336–1345. doi:10.1074/jbc.M406968200.
Spiegel, M., and Weber, F. (2006). Inhibition of cytokine gene expression and induction of chemokine genes in non-lymphatic cells infected with SARS coronavirus. Virol. J. 3, 17. doi:10.1186/1743-422X-3-17.
SRA Handbook [Internet]. Using the SRA (2010). Bethesda Natl. Cent. Biotechnol. Inf.
Sun, J., Ye, F., Wu, A., Yang, R., Pan, M., and Sheng, J. (2020). Comparative transcriptome analysis reveals the intensive early-stage responses of host cells to SARS-CoV-2 infection. medRxiv(preprint).
Szklarczyk, D., Franceschini, A., Wyder, S., Forslund, K., Heller, D., Huerta-Cepas, J., et al. (2015). STRING v10: protein–protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 43, D447–D452. doi:10.1093/nar/gku1003.
Tang, B. S. F., Chan, K., Cheng, V. C. C., Woo, P. C. Y., Lau, S. K. P., Lam, C. C. K., et al. (2005). Comparative Host Gene Transcription by Microarray Analysis Early after Infection of the Huh7 Cell Line by Severe Acute Respiratory Syndrome Coronavirus and Human Coronavirus 229E. J. Virol. 79, 6180–6193. doi:10.1128/JVI.79.10.6180-6193.2005.
van Boheemen, S., de Graaf, M., Lauber, C., Bestebroer, T. M., Raj, V. S., Zaki, A. M., et al. (2012). Genomic Characterization of a Newly Discovered Coronavirus Associated with Acute Respiratory Distress Syndrome in Humans. MBio 3. doi:10.1128/mBio.00473-12.
Walls, A. C., Park, Y.-J., Tortorici, M. A., Wall, A., McGuire, A. T., and Veesler, D. (2020). Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell 181, 281-292.e6. doi:10.1016/j.cell.2020.02.058.
Wan, Y., Shang, J., Graham, R., Baric, R. S., and Li, F. (2020). Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus. J. Virol. 94. doi:10.1128/JVI.00127-20.
Wang, N., Shi, X., Jiang, L., Zhang, S., Wang, D., Tong, P., et al. (2013). Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4. Cell Res. 23, 986–993. doi:10.1038/cr.2013.92.
Wang, W., Xu, Y., Gao, R., Lu, R., Han, K., Wu, G., et al. (2020). Detection of SARS-CoV-2 in Different Types of Clinical Specimens. JAMA. doi:10.1001/jama.2020.3786.
Wangzhou, A., Paige, C., Neerukonda, S. V, Dussor, G., Ray, P. R., and Price, T. J. (2020). A pharmacological interactome platform for discovery of pain mechanisms and targets. bioRxiv(preprint), 2020.04.14.041715. doi:10.1101/2020.04.14.041715.
Yu, G., Wang, L.-G., Han, Y., and He, Q.-Y. (2012). clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters. Omi. A J. Integr. Biol. 16, 284–287. doi:10.1089/omi.2011.0118.
Zhang, X., Chu, H., Wen, L., Shuai, H., Yang, D., Wang, Y., et al. (2020). Competing endogenous RNA network profiling reveals novel host dependency factors required for MERS-CoV propagation. Emerg. Microbes Infect. 9, 733–746. doi:10.1080/22221751.2020.1738277.
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., et al. (2020). A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270–273. doi:10.1038/s41586-020-2012-7.
Zhu, A., Ibrahim, J. G., and Love, M. I. (2019). Heavy-tailed prior distributions for sequence count data: removing the noise and preserving large differences. Bioinformatics 35, 2084–2092. doi:10.1093/bioinformatics/bty895.
Zlotnik, A., Burkhardt, A. M., and Homey, B. (2011). Homeostatic chemokine receptors and organ-specific metastasis. Nat. Rev. Immunol. 11, 597–606. doi:10.1038/nri3049.
Zlotnik, A., and Yoshie, O. (2012). The Chemokine Superfamily Revisited. Immunity 36, 705–716. doi:10.1016/j.immuni.2012.05.008.